Use of Porcine Xenografts in Dermatology Surgery: The Mayo Clinic Experience
Authors:
- 1 August 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 42 (8) , 985-991
Abstract
BACKGROUND: Knowledge regarding the use of xenografts in cutaneous surgery is limited. OBJECTIVE: We sought to better understand the utility, outcomes, and complications of porcine xenograft applications in cutaneous surgery. METHODS AND MATERIALS: A single center, retrospective study of patients with porcine xenograft applications was completed. Characteristics of tumors, surgical procedures, resulting wound beds, follow-up care, and final length of follow-up were determined, and statistical analysis was conducted. RESULTS: Of 225 porcine xenograft placements in 220 patients, the majority of tumors were nonmelanoma skin cancers (89%) and similarly divided between the head (excepting nose/ear), nose, ear, and extremities. Both Mohs and standard excision resulted in a 5.7 cm2 mean area of surgical defect, with the majority closed by porcine xenograft only (84.1%), and healing by secondary intention (97.3%). The area of surgical defect and topical antibiotics contributed to increased length of time to final follow-up. CONCLUSION: The data represent the largest series of biologic dressings in cutaneous surgery and demonstrate the applicability and safety of porcine xenografts. We recommend consideration of porcine xenografts in the appropriate clinical context, to augment secondary intention.Keywords
This publication has 12 references indexed in Scilit:
- Use of Porcine Xenografts on Partial-Thickness Vermilion Border and Mucosal Lower Lip Mohs DefectsDermatologic Surgery, 2013
- Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell CarcinomaJournal of Investigative Dermatology, 2013
- Biologic Skin Substitutes and Their Applications in DermatologyDermatologic Surgery, 2013
- Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006Archives of Dermatology, 2010
- Letter: Re: Risks of Infection in Dermatologic Surgical Wounds Resulting from Biologic DressingsDermatologic Surgery, 2010
- Biologic DressingsDermatologic Surgery, 2009
- “Xenograft” dressing in the treatment of burnsClinics in Dermatology, 2005
- Bacitracin after clean surgical procedures may be riskyJournal of the American Academy of Dermatology, 2004
- Infection and Allergy Incidence in Ambulatory Surgery Patients Using White Petrolatum vs Bacitracin OintmentJAMA, 1996
- Postoperative Wound Infection Rates in Dermatologic SurgeryDermatologic Surgery, 1995